Recent Publications Citing the Center for Drug Discovery (formerly known as the Drug Discovery Program)

Hou, S.; Yi, Y. W.; Kang, H. J.; Zhang, L.; Kim, H. J.; Kong, Y.; Liu, Y.; Wang, K.; Kong, H.; Grindrod, S.; Bae, I.; Brown, M. L., Novel Carbazole Inhibits Phospho-STAT3 Through Induction of Protein Tyrosine Phosphatase PTPN6. J Med Chem 2014. [Epub ahead of print]

Paige, M.; Wang, K.; Burdick, M.; Park, S.; Cha, J.; Jeffery, E.; Sherman, N.; Shim, Y. M., Role of leukotriene A4 hydrolase aminopeptidase in the pathogenesis of emphysema. J Immunol 2014, 192 (11), 5059-68.

Assefnia, S.; Dakshanamurthy, S.; Auvil, J. M.; Hampel, C.; Anastasiadis, P. Z.; Kallakury, B.; Uren, A.; Foley, D. W.; Brown, M. L.; Shapiro, L.; Brenner, M.; Haigh, D.; Byers, S. W., Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies. Oncotarget 2014, 5 (6), 1458-74.

Liu, Y.; Paige, M.; Olson, T. T.; Al-Muhtasib, N.; Xie, T.; Hou, S.; White, M. P.; Cordova, A.; Guo, J. L.; Kellar, K. J.; Xiao, Y.; Brown, M. L.; Synthesis and Pharmacological Characterization of New Neuronal Nicotinic Acetylcholine Receptor Ligands Derived from Sazetidine-A. Bioorg Med Chem Lett 2014, 24 (13) 2954-56

Donahue, T. J.; Hillhouse, T. M.; Webster, K. a; Young, R.; De Oliveira, E. O.; Porter, J. H. (S)-Amisulpride as a Discriminative Stimulus in C57BL/6 Mice and Its Comparison to the Stimulus Effects of Typical and Atypical Antipsychotics. Eur. J. Pharmacol. 2014, 734C, 15–22.

Paige, M.; Kosturko, G.; Bulut, G.; Miessau, M.; Rahim, S.; Toretsky, J. A.; Brown, M. L.; Uren, A., Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma. Bioorg Med Chem 2014, 22 (1), 478-87.

Fan, S.; Meng, Q.; Xu, J.; Jiao, Y.; Zhao, L.; Zhang, X.; Sarkar, F. H.; Brown, M. L.; Dritschilo, A.; Rosen, E. M., DIM (3,3'-diindolylmethane) confers protection against ionizing radiation by a unique mechanism. Proc Natl Acad Sci USA 2013, 110 (46), 18650-5. PMID: 24127581

Levin, E. D.; Sexton, H. G.; Gordon, K.; Gordon, C. J.; Xiao, Y.; Kellar, K. J.; Yenugonda, V. M.; Liu, Y.; White, M. P.; Paige, M.; Brown, M. L.; Rezvani, A. H., Effects of the sazetidine-a family of compounds on the body temperature in wildtype, nicotinic receptor β2-/- and α7-/- mice. Eur J Pharmacol 2013, 718 (1-3), 167-172. PMID: 24036108

Yenugonda, V. M.; Xiao, Y.; Levin, E. D.; Rezvani, A. H.; Tran, T.; Al-Muhtasib, N.; Sahibzada, N.; Xie, T.; Wells, C.; Slade, S.; Johnson, J. E.; Dakshanamurthy, S.; Kong, H.; Tomita, Y.; Liu, Y.; Paige, M.; Kellar, K. J.; Brown, M. L., Design, Synthesis and Discovery of Picomolar Selective α4β2 Nicotinic Acetylcholine Receptor Ligands. J Med Chem 2013. PMID:24047231

Liu, Y.; Richardson, J.; Tran, T.; Al-Muhtasib, N.; Xie, T.; Yenugonda, V. M.; Sexton, H. G.; Rezvani, A. H.; Levin, E. D.; Sahibzada, N.; Kellar, K. J.; Brown, M. L.; Xiao, Y.; Paige, M., Chemistry and Pharmacological Studies of 3-Alkoxy-2,5-Disubstituted-Pyridinyl Compounds as Novel Selective α4β2 Nicotinic Acetylcholine Receptor Ligands That Reduce Alcohol Intake in Rats. J Med Chem 2013. PMID: 23540678

molpharm2007cover Timofeeva, O. A.; Tarasova, N. I.; Zhang, X.; Chasovskikh, S.; Cheema, A. K.; Wang, H.; Brown, M. L.; Dritschilo, A., STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domain. Proc Natl Acad Sci U S A 2013, 110, 1267-1272. PMID: 23288901

Dumanis, S. B.; DiBattista, A. M.; Miessau, M.; Moussa, C. E.; Rebeck, G. W., APOE genotype affects the pre-synaptic compartment of glutamatergic nerve terminals. J Neurochem 2013, 124, 4-14. PMID: 22862561

Yi, Y. W.; Kang, H. J.; Kim, H. J.; Kong, Y.; Brown, M. L.; Bae, I. Targeting Mutant p53 by a SIRT1 Activator YK-3-237 Inhibits the Proliferation of Triple-Negative Breast Cancer Cells. Oncotarget 2013, 4, 984-94. PMID: 23846322

Yenugonda, V. M.; Kong, Y.; Deb, T. B.; Yang, Y.; Riggins, R. B.; Brown, M. L. Trans-resveratrol boronic acid exhibits enhanced anti-proliferative activity on estrogen-dependent MCF-7 breast cancer cells. Cancer Biol Ther 2012, 13, 925-934. PMID: 22785207

Walls, T. H.; Grindrod, S. C.; Beraud, D.; Zhang, L.; Baheti, A. R.; Dakshanamurthy, S.; Patel, M. K.; Brown, M. L.; MacArthur, L. H., Synthesis and biological evaluation of a fluorescent analog of phenytoin as a potential inhibitor of neuropathic pain and imaging agent. Bioorg Med Chem 2012, 20, 5269-5276. PMID: 22863530

Timofeeva, O. A.; Chasovskikh, S.; Lonskaya, I.; Tarasova, N. I.; Khavrutskii, L.; Tarasov, S. G.; Zhang, X.; Korostyshevskiy, V. R.; Cheema, A.; Zhang, L.; Dakshanamurthy, S.; Brown, M. L.; Dritschilo, A., Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA. J Biol Chem 2012, 287, 14192-14200. PMID: 22378781

Sirajuddin, P.; Das, S.; Ringer, L.; Rodriguez, O. C.; Sivakumar, A.; Lee, Y. C.; Uren, A.; Fricke, S. T.; Rood, B.; Ozcan, A.; Wang, S. S.; Karam, S.; Yenugonda, V.; Salinas, P.; Petricoin, E., 3rd; Pishvaian, M.; Lisanti, M. P.; Wang, Y.; Schlegel, R.; Moasser, B.; Albanese, C., Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI. Cell Cycle 2012, 11, 3801-3809. PMID: 22983062

Kong, H. S.; Tian, S.; Kong, Y.; Du, G.; Zhang, L.; Jung, M.; Dritschilo, A.; Brown, M. L., Preclinical studies of YK-4-272, an inhibitor of class II histone deacetylases by disruption of nucleocytoplasmic shuttling. Pharm Res 2012, 29, 3373-3383. PMID: 22836184 CBTCover2009

Johnson, J. E.; Slade, S.; Wells, C.; Petro, A.; Sexton, H.; Rezvani, A. H.; Brown, M. L.; Paige, M. A.; McDowell, B. E.; Xiao, Y.; Kellar, K. J.; Levin, E. D., Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats. Psychopharmacology (Berl) 2012, 222, 269-276. PMID: 22297831

Hartley, R. M.; Peng, J.; Fest, G. A.; Dakshanamurthy, S.; Frantz, D. E.; Brown, M. L.; Mooberry, S. L., Polygamain, a new microtubule depolymerizing agent that occupies a unique pharmacophore in the colchicine site. Mol Pharmacol 2012, 81, 431-439. PMID: 22169850

Davis, G. C.; Kong, Y.; Paige, M.; Li, Z.; Merrick, E. C.; Hansen, T.; Suy, S.; Wang, K.; Dakshanamurthy, S.; Cordova, A.; McManus, O. B.; Williams, B. S.; Chruszcz, M.; Minor, W.; Patel, M. K.; Brown, M. L., Asymmetric synthesis and evaluation of a hydroxyphenylamide voltage-gated sodium channel blocker in human prostate cancer xenografts. Bioorg Med Chem 2012, 20, 2180-2188. PMID: 22364743

Algarzae, N.; Hebron, M.; Miessau, M.; Moussa, C. E., Parkin prevents cortical atrophy and Abeta-induced alterations of brain metabolism: (1)(3)C NMR and magnetic resonance imaging studies in AD models. Neuroscience 2012, 225, 22-34. PMID: 22960314

Barber-Rotenberg, J. S.; Selvanathan, S. P.; Kong, Y.; Erkizan, H. V.; Snyder, T. M.; Hong, S. P.; Kobs, C. L.; South, N. L.; Summer, S.; Monroe, P. J.; Chruszcz, M.; Dobrev, V.; Tosso, P. N.; Scher, L. J.; Minor, W.; Brown, M. L.; Metallo, S. J.; Uren, A.; Toretsky, J. A. Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1. Oncotarget 2012, 3, 172-82. PMID: 22383402

Dakshanamurthy, S.; Issa, N. T.; Assefnia, S.; Seshasayee, A.; Peters, O. J.; Madhavan, S.; Uren, A.; Brown, M. L.; Byers, S. W. Predicting New Indications for Approved Drugs Using a Proteochemometric Method. Journal of Medicinal Chemistry 2012, 55, 6832-6848. PMID:22780961

Recent Abstracts

Kong, H. S.; Song, J.; Yenugonda, V. M.; Zhang, L.; Tian, S.; Kong, Y.; Xiao, Y.; Kellar, K. J.; Du, G.; Paige, M.; Brown, M. L.; Bioavailability and Pharmacokinetic Studies of VMY-2-95·2HCl, a Potent and Selective Nicotinic α4β2 Receptor Ligand. AAPS Annual Meeting and Exposition, San Antonio, TX, November 10-14, 2013


Levin, E. D.; Slade, S.; Wells, C.; Rezvani, A. H.; Xiao, Y.; Kellar, K. J.; Yenugonda, V. M.; Paige, M.; Brown, M. L.; The α4β2 nicotinic desensitizing agent VMY 2-109 significantly decreases nicotine self-administration in rats. Society for Neurosciences, San Diego, CA, Nov 9-13, 2013.


Das, A. et al.  Investigation of novel thalidomide-based pro-angiogenic small molecules through gene network analysis. 2153. Bioinformatics, Computational and Systems Biology.  Biomedical Engineering Society (BMES) Annual Meeting, September 25-28, 2013, Seattle, Washington.


Yenugonda, V. M.; Deb, T. B.; Brown, M. L.;  Development of Novel CDK1 Small Molecule ‘VMY-1-103’ for Inhibition of Triple Negative Breast Cancer Cell Growth.  Sixth Annual Frontiers at the Chemistry-Biology Interface Symposium (FCBIS), College Park, Maryland, May 4, 2013. 



De Oliveira, E. O.; Ma, Y.; Tomita, Y.; Rosen, E.; Brown, M. L.; Discovery and Development of Novel 4-Aminopyrimidines (A9 analogs) as Potential BRCA-1 Mimetic Drugs for the Treatment of Breast Cancer. Abstract 2458. American Association for Cancer Research (AACR), Washington, DC, April 6-10, 2013.


Ellingson, S. R.; Dakshanamurthy, S.; Brown, M. L.; Smith, J. C.,; Baudry. J. Accelerating Virtual High-Throughput Ligand Docking: Screening One Million Compounds Using a Petascale Supercomputer. The 3rd International Emerging Computational Methods for the Life Sciences Workshop Date Proceedings. Association for Computing Machinery. 2012.

Yenugonda, V. M.; Xiao, Y.; Levin, E.D.; Rezvani, A.H.; Tran, T.; Al-Muhtasib, N.; Wells, C.; Slade, S.; Johnson, J. E.; Kong, H. S.; Dakshanamurthy, S.; Tomita, Y.; Liu, Y.; Paige, M.A.;  Kellar, K.J.; Brown, M.L.; Design, Synthesis and Characterization of Picomolar Selective α4β2 Nicotinic Acetylcholine Receptor Inhibitors. 244th American Chemical Society National Meeting  (Abstract # 11608 and SciMix Paper # 33), August 19, 2012, Philadelphia, PA.

Slade, S.; Wells, C.; Burke, D.; Johnson, J. E.; Resvani, A. H.; Kellar, K. J.; Xiao, Y.;  Yenogonda, V.M.; Paige, M. A.; Brown, M. L.; Levin, E. D. The α4β2 nicotinic desensitizing agent VMY-2-95 decreases nicotine self-administration in rats. Society for Neuroscience. Oct 15, 2012.

Levin, E. D.; Cousins, V.; Jonhson, J.; Slade, S.; Wells, C.; Resvani, A. H.; Xiao, Y.; Brown, M. L.; Paige, M. A.; Kellar. K. J.; Nicotinic α4β2 desensitizing agents and nicotine self-administration in rats.  Meeting of the Society for Research on Nicotine and Tobacco Europe, Helsinki, Finland, August 30-Sept. 2, 2012.

Kong, H. S.; Tian, S.; Xiao, Y.; Kellar, K. J.; Du, G.; Paige, M. A.; Brown, M. L. Preclinical Studies on Sazetidine-A, A Selective and Potent α4β2 Antagonist. 2012 American Association of Pharmaceutical Scientists Annual Meeting. October 15, 2012.

Sirajuddin, P.; Das, S.; Ringer, L.; Salinas, P.; Rodriguez, O.; Brown, M. L.; Yenugonda, V. M.; Moasser, B.; Albanese, C.  LC-MS/MS detection of the dansyl-modified biologically active CDK inhibitor VMY-1-103 using an in vivo model system. AACR Annual Meeting 2012 Abstract #4774.

Ringer, L.; Sirajuddin, P.; Yenugonda, V. M.; Brown, M. L.; Rodriguez, O.; Albanese, C. Role of p53 in cdk inhibitor VMY-1-103-induced apoptosis in prostate cancer (abstract # 3052) In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72 (8 Suppl): doi:1538-7445.AM2012-3052.

Xiao, Y.; Tuan, E.; Sahibzada, N.; Tran, T.; Al-Muhtasib, N.; Yasuda, R. P.; Liu, Y.; Yenugonda, V. M.; Paige, M.; Brown, M. L.; Kellar, K. J. Comparison of pharmacological properties of human vs rat α4β2 and α3β4 nicotinic acetylcholine receptors stably expressed in HEK293 cells. Neuroscience Meeting. New Orleans, LA. 2012 (640.15/C45)

Donahue, T. J.; Webster, K. A.; Hillhouse, T. M.; De Oliveira, E. O.; Porter, J. H.; Discriminative stimulus properties of the atypical antipsychotic amisulpride in C57BL/6 mice. Society for Neurosciences, New Orleans, LA (2012) 452.17/M20.